<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta name="robots" content="noindex">
<link rel="stylesheet" href="https://img.medscape.com/medcss/1024/articlewide.css" type="text/css" media="all" />
<link rel="stylesheet" href="https://img.medscape.com/medscape-core/common/css/global/medscape-print3.css" type="text/css" media="all" />
<style type="text/css" media="print">
      <!-- .hidefromprinter {display: none;} -->
   </style>

<!-- basic header  -->
<link rel="stylesheet" href="//img.medscapestatic.com/medcss/medscape-print.css" type="text/css" media="all" />
<link rel="stylesheet" href="//img.medscapestatic.com/medscape-core/common/css/header/header-basic.css" type="text/css" media="all" />
<link rel="stylesheet" href="//img.medscapestatic.com/medscape-core/common/css/footer/footer-basic.css" type="text/css" media="all" />
<link rel="stylesheet" href="//img.medscapestatic.com/medscape-core/common/css/footer/footer-basic.css" type="text/css" media="all" />
<script type="text/javascript" src="//www.medscape.com/files/scripts/swfobject.js"></script>
<script type="text/javascript" src="//www.medscape.com/files/scripts/swfobject2.js"></script>
<script type="text/javascript" src="//img.medscapestatic.com/medscape-core/cme/js/article/edu-article-print.js"></script>

  <script>!function(a){var e="https://s.go-mpulse.net/boomerang/",t="addEventListener";if("False"=="True")a.BOOMR_config=a.BOOMR_config||{},a.BOOMR_config.PageParams=a.BOOMR_config.PageParams||{},a.BOOMR_config.PageParams.pci=!0,e="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="HJ8LM-W7VE6-JP7B8-AUPDS-2SLPG",function(){function n(e){a.BOOMR_onload=e&&e.timeStamp||(new Date).getTime()}if(!a.BOOMR||!a.BOOMR.version&&!a.BOOMR.snippetExecuted){a.BOOMR=a.BOOMR||{},a.BOOMR.snippetExecuted=!0;var i,_,o,r=document.createElement("iframe");if(a[t])a[t]("load",n,!1);else if(a.attachEvent)a.attachEvent("onload",n);r.src="javascript:void(0)",r.title="",r.role="presentation",(r.frameElement||r).style.cssText="width:0;height:0;border:0;display:none;",o=document.getElementsByTagName("script")[0],o.parentNode.insertBefore(r,o);try{_=r.contentWindow.document}catch(O){i=document.domain,r.src="javascript:var d=document.open();d.domain='"+i+"';void(0);",_=r.contentWindow.document}_.open()._l=function(){var a=this.createElement("script");if(i)this.domain=i;a.id="boomr-if-as",a.src=e+"HJ8LM-W7VE6-JP7B8-AUPDS-2SLPG",BOOMR_lstart=(new Date).getTime(),this.body.appendChild(a)},_.write("<bo"+'dy onload="document._l();">'),_.close()}}(),"".length>0)if(a&&"performance"in a&&a.performance&&"function"==typeof a.performance.setResourceTimingBufferSize)a.performance.setResourceTimingBufferSize();!function(){if(BOOMR=a.BOOMR||{},BOOMR.plugins=BOOMR.plugins||{},!BOOMR.plugins.AK){var e=""=="true"?1:0,t="",n="vrcpldix2jqjux5lbcaq-f-dce0b6d33-clientnsv4-s.akamaihd.net",i={"ak.v":"29","ak.cp":"84216","ak.ai":parseInt("361167",10),"ak.ol":"0","ak.cr":45,"ak.ipv":4,"ak.proto":"http/1.1","ak.rid":"cecb4bf","ak.r":35865,"ak.a2":e,"ak.m":"","ak.n":"essl","ak.bpcip":"5.145.220.0","ak.cport":40016,"ak.gh":"92.122.245.39","ak.quicv":"","ak.tlsv":"tls1.2","ak.0rtt":"","ak.csrc":"-","ak.acc":"reno","ak.t":"1605044353","ak.ak":"hOBiQwZUYzCg5VSAfCLimQ==k+gxYs20pIyo9A9JlbkXhDcNJ5XWpRC/8Hl3Ax6e51DMkhUdFjI7u/1KyLgg6r1zjaMJnY0SbfXLg0sDl2pbyUlINnAIElMuWfc7JnP9G4BqNlAL6dGgfwDww+Lr+OgdWqTBisgQWscX6Am2AV40bvHKv34fmVs8NwQ5iaGZyZs5R+5kbGUftBwCidXBYnSMPkR4GjhDujy77+U+OhNm/jg6SDhJJD2S2nxNJboCAzC0gUlXvYyp9UWSyxx11y5W+b1DKwkI2wrjqpHDNNuIxT7XbO87uD91IJNmYpnlAj1UXdvSDU/Fm4byxIDKAZAzbyWVRW14YyNoUS6xptZkF00Dsggz6FCcwTS+Ns3tmUeJPkSvWs8rKH5/t+pukWGWF0spD8lOR/ePPr4AAdlMnuumoQOhDoN6aMLPrrBZrLI=","ak.pv":"64","ak.dpoabenc":""};if(""!==t)i["ak.ruds"]=t;var _={i:!1,av:function(e){var t="http.initiator";if(e&&(!e[t]||"spa_hard"===e[t]))i["ak.feo"]=void 0!==a.aFeoApplied?1:0,BOOMR.addVar(i)},rv:function(){var a=["ak.bpcip","ak.cport","ak.cr","ak.csrc","ak.gh","ak.ipv","ak.m","ak.n","ak.ol","ak.proto","ak.quicv","ak.tlsv","ak.0rtt","ak.r","ak.acc","ak.t"];BOOMR.removeVar(a)}};BOOMR.plugins.AK={akVars:i,akDNSPreFetchDomain:n,init:function(){if(!_.i){var a=BOOMR.subscribe;a("before_beacon",_.av,null,null),a("onbeacon",_.rv,null,null),_.i=!0}return this},is_complete:function(){return!0}}}}()}(window);</script></head>
<body>
<div id="bodypadding">
<!-- Medscape Header -->
<div id="basicheader">
<div class="spacer">&nbsp;</div>
<div class="row">



<div id="basicheaderlinks">
<a href="http://www.medscape.com">www.medscape.com</a>
</div>

</div>
<div class="spacer">&nbsp;</div>
</div>
<!-- /Medscape Header -->
<div id="contentbody">
 <!--create-article-print-->
 <div id="article-content">
  <h1 class="title">Ongoing Analyses Suggest Cefepime Does Not Increase Death Risk</h1>
  <p class="meta-date">June&nbsp;17,&nbsp;2009</p>
  <div id="ads-pos-1122" class="AdUnit"></div>
  <script>webmd.ads2.defineAd({id:'ads-pos-1122',pos: 1122});</script> 
  <p>June 17, 2009 вЂ” Cefepime HCl injection (<i>Maxipime</i>, Bristol-Myers Squibb Co) does not appear to increase the risk for death compared with comparator medications as reported previously, according to a review of data by the US Food and Drug Administration (FDA).</p> 
  <p>In an alert sent today from MedWatch, the FDA's safety information and adverse event reporting program, the FDA notified healthcare professionals that it has finished its analysis of data indicating a possible risk of higher death with cefepime, which was <a href="http://www.medscape.com/viewarticle/565952 " target="_blank">first reported</a> in 2007.</p>
  <div class="txtAd520SpcHolder" id="plcHold-520">
   <div id="ads-pos-520" class="AdUnit"></div>
  </div>
  <script>webmd.ads2.defineAd({id:'ads-pos-520',pos: 520});</script> 
  <p>According to the FDA, the most recent data "do not indicate a higher rate of death in cefepime-treated patients," and "cefepime remains an appropriate therapy for its approved indications."</p>
  <div id="ads-pos-1520" class="AdUnit"></div>
  <script>webmd.ads2.defineAd({id:'ads-pos-1520',pos: 1520});</script> 
  <p>Cefepime is a fourth-generation cephalosporin and member of the beta-lactam class of antibacterial drugs with an extended spectrum of activity against gram-positive and gram-negative bacteria.</p> 
  <p>In November 2007, the FDA announced that it was evaluating findings of a meta-analysis published by Yahav and colleagues in the May 2007 issue of <i>The Lancet Infectious Diseases</i>, which included mortality data from 38 clinical trials. The study reported that 30-day all-cause mortality was higher with cefepime compared with other beta-lactams (risk ratio [RR], 1.26; 95% confidence interval [CI], 1.08 - 1.49). Mortality risk was further elevated when only studies including febrile neutropenia were assessed, with a 42% increased risk for 30-day all-cause mortality associated with cefepime (RR, 1.42; 95% CI, 1.09 - 1.84]).</p> 
  <p>In the current FDA analysis, which included 50 additional trials not included in the Yahav study for a total of 88 trials, no statistically significant difference in mortality was observed between cefepime and the comparators.In addition, the meta-analysis of 24 febrile neutropenia trials also did not show a statistically significant increased mortality risk in cefepime-treated patients compared with those treated with comparators.</p>
  <div class="AdUnit adSpcHolder" id="plcHold-141">
   <div id="ads-pos-141" class="AdUnit"></div>
  </div>
  <script>webmd.ads2.defineAd({id:'ads-pos-141',pos: 141});</script>
  <div id="ads-pos-1420" class="AdUnit"></div>
  <script>webmd.ads2.defineAd({id:'ads-pos-1420',pos: 1420});</script> 
  <p>The review is ongoing, and the FDA, along with Bristol-Myers Squibb, will be conducting separate analyses of in-hospital data of antibiotic use to further evaluate this issue. The results are expected within a year.</p>
  <div class="inContentAd"></div> 
  <p>Adverse events related to use of cefepime therapy should be communicated to the FDA's MedWatch reporting program by telephone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, online at <a href="http://www.fda.gov/medwatch" target="_blank">http://www.fda.gov/medwatch</a>, or by mail to 5600 Fishers Lane, Rockville, Maryland 20852-9787.</p>
  <div class="inContentAd"></div> 
  <p>More information is available on the <a href="http://www.fda.gov/medwatch/safety/2009/safety09.htm#Ceftriaxone " target="_blank">FDA's MedWatch Web site</a>.</p>
  <div class="inContentAd"></div> 
 </div>
 <div id="legal_block">
  <bkmtr-front xmlns:dctm="http://www.documentum.com" xmlns:fmt="http://java.sun.com/jstl/fmt" xmlns:jsp="jsp"></bkmtr-front>
  <p>Medscape Medical News&nbsp;В©&nbsp;2009&nbsp;<br></p>
  <p id="citation">
   <!--news alert-->Cite this: Ongoing Analyses Suggest Cefepime Does Not Increase Death Risk&nbsp;-&nbsp;<i>Medscape</i>&nbsp;-&nbsp;Jun&nbsp;17,&nbsp;2009.</p>
 </div>
</div></div>
<!-- /bodypadding -->
<iframe width="0" height="0" style="display:none;" src="https://img.webmd.com/medscape/netbeacon.html?domain=webmd.com&guid=1186110&usp=208&pf=10&ct=ru&occ=0&st="></iframe>
<script language="javascript1.2" type="text/javascript"><!-- 
	var s_account = "webmdcom"
	var s_user_group = "Physician"
	var s_user_origin = "ru"
	var s_user_specialty = "Undefined"
	var s_registered_user_id = "32024970"
	var s_auth_channel_id = "101"
	var s_profession_id = "10"
	var s_user_specialty_id = "208"

//-->
</script>
<script language="javascript1.2" type="text/javascript"
src="https://img.medscapestatic.com/pi/scripts/omniture/bi_medscape.js?d=11/10/2020"></script>

<!-- Communications Platform  -->
<script type="text/javascript" src="//img.medscapestatic.com/medscape-core/shared-all/js/cp/cp.js?v=20180816"></script>
<!-- /Communications Platform  -->

<!-- multisite include -->

<script type="text/javascript">var isMscpApp = false;</script>
	<script type="text/javascript">var isEuUser = true;</script>
			<script type="text/javascript" src="//img.medscapestatic.com/medscape-core/shared-all/js/gdpr/gdpr.js"></script>
		<!-- CCPA disclosure bar -->
<div id="consent_blackbar"></div>
<script async="async" type="text/javascript" src="//consent.trustarc.com/notice?domain=medscape.com&c=teconsent&js=nj&noticeType=bb&text=true&cookieLink=https%3A%2F%2Fwww.medscape.com%2Fpublic%2Fcalifornia-privacy&privacypolicylink=https%3A%2F%2Fwww.medscape.com%2Fpublic%2Fprivacy"></script>
<style>
#truste-consent-track{position:fixed;bottom:0;width:100%;z-index:6010000}.truste-messageColumn,.truste-button1,.truste-cookie-link{font-family:'proxima_nova_rgregular'}.truste-banner a:link{color:#007cb0}.truste-banner a:hover{color:#005b81}@media screen and (max-width:790px){.truste-button2{position:absolute;top:20px}.truste-messageColumn,.truste-cookie-link{font-size:16px}#truste-cookie-button{font-size:18px}}
</style>
<!-- /CCPA disclosure bar -->

<script type="text/javascript" src="//img.medscapestatic.com/medscape-core/shared-all/js/medscape/medscape-site.js"></script>
<!-- /multisite include --><script type="text/javascript" src="//img.medscapestatic.com/medscape-core/common/js/global/global-ext-lib.js"></script> 
<script type="text/javascript" src="//img.medscapestatic.com/medscape-core/qna-lib/js/qna.min.js"></script>
<script type="text/javascript">
	$().ready(function() {
		window.print();
	})
</script>
</body>

</html>
